Anbio Biotechnology (NNNN) Enterprise Value (2025 - 2026)
Anbio Biotechnology's Enterprise Value history spans 3 years, with the latest figure at -$11.9 million for Q4 2025.
- Quarterly Enterprise Value fell 1.19% to -$11.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$11.9 million through Dec 2025, down 1.19% year-over-year, with the annual reading at -$11.9 million for FY2025, 1.19% down from the prior year.
- Enterprise Value came in at -$11.9 million for Q4 2025, up from -$13429.0 billion in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$9.7 million in Q4 2023 to a low of -$13429.0 billion in Q2 2025.
- The 3-year median for Enterprise Value is -$11.8 million (2024), against an average of -$3357.3 billion.
- Year-over-year, Enterprise Value dropped 21.36% in 2024 and then decreased 1.19% in 2025.
- Anbio Biotechnology's Enterprise Value stood at -$9.7 million in 2023, then decreased by 21.36% to -$11.8 million in 2024, then dropped by 1.19% to -$11.9 million in 2025.
- Per Business Quant, the three most recent readings for NNNN's Enterprise Value are -$11.9 million (Q4 2025), -$13429.0 billion (Q2 2025), and -$11.8 million (Q4 2024).